1983年，作为中国第一家从事医药进出口贸易的专业化公司，中国医药保健品有限公司前身中国医药保健品进出口总公司正式成立。
In 1983, as China’s first specialized pharmaceutical import and export trade company, China National Medicines & Health Products Import & Export Corporation, the predecessor of China Meheco Corporation, was officially established.
公司发展面向国内、国际两个市场，桥接国内外高端资源，可在医药制剂、原料药及中间体、医疗设备、医用耗材、中药材、提取物等领域为客户提供多元化产品；在医院与药厂建设、政府采购、对外援助等项目中为客户提供包括项目设计、产品供应、售后维护等在内的专业化集成解决方案；在市场营销方面为客户提供产品注册、渠道拓展、市场推广、终端维护等在内的一体化配套服务。
The Company operates across both domestic and international markets, integrating high-quality resources worldwide. It provides a diverse portfolio of products, including pharmaceutical formulations, active pharmaceutical ingredients (APIs) and intermediates, medical equipment, medical consumables, traditional Chinese medicinal materials, and plant extracts. The Company offers integrated and professional solutions for hospitals and pharmaceutical plant construction, government procurement, and foreign aid projects, covering project design, product supply, and after-sales service. In marketing, it delivers comprehensive support services such as product registration, channel development, market promotion, and end-user engagement.
经过40余年的发展，公司已拥有成熟的项目集成服务、医疗产品营销两大业务板块，在香港、巴西、墨西哥等地成立子公司，在拉美、北非、中亚等地区设有海外分支机构，营销网络遍布全球。
After more than 40 years of development, the Company has established two core business segments: project integration services and medical product marketing. It has set up subsidiaries in Hong Kong, Brazil, and Mexico, and established overseas branches in regions including Latin America, North Africa, and Central Asia, with a global marketing network.
公司业务遍布100多个国家和地区，覆盖国内30个省（直辖市、自治区），与国内外60余家大型医疗集团、50000余家商业客户开展合作，为全球20000余家医疗机构（包括国内1000余家三甲医院）提供产品及服务。公司已成长为一家国际化经营的医药及医疗器械综合服务商，可为国内外市场各类客户提供专业化解决方案。
Our business spans more than 100 countries and regions and covers 30 provinces, municipalities, and autonomous regions across China. We have established partnerships with more than 60 large-scale medical groups and over 50,000 commercial clients worldwide, providing products and services to more than 20,000 medical institutions, including over 1,000 top-tier hospitals across China. The Company has grown into an internationally operated comprehensive service provider in pharmaceuticals and medical devices, delivering professional solutions to clients in both domestic and global markets.
